Form of glycopyrronium chloride

PK201100430A0Undetermined Publication Date: 2011-06-22CHIESI FARMACEUTICI SPA
0 Cites 0 Cited by

Patent Information

Application Number
PK201100430
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2011-06-11
Publication Date
2011-06-22
Patent Text Reader

Abstract

The invention concerns a novel Crystalline (3R,2’S)- and (3S,2'R)-[(cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium chloride (threo glycopyrronium chloride) monohydrate, having the following characteristic XRPD peaks at 2θ in angular degrees using Cu-Kα radiation (accuracy ± 0.1°): 5.40; 10.65; 11.32; 12.46; 14.88; 17.16; 18.47; 18.69; 19.24; 22.08; 22.74; 25.40; 25.54; 26.57; and 28.42 and its use in pharmaceutical applications.
Need to check novelty before this filing date? Find Prior Art